Login / Signup
Huanlong Liu
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Locally Advanced
Chemotherapy Induced
Small Cell Lung Cancer
Top Venues
Expert review of pharmacoeconomics & outcomes research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Shuo Kang
,
Huanlong Liu
Cost-effectiveness of adding serplulimab to first-line chemotherapy for extensive-stage small-cell lung cancer in China.
Expert review of pharmacoeconomics & outcomes research
(2023)